MedPath
NMPA Approval

Indobufen Tablets

国药准字H20249478

December 1, 2024

Drug Information

吲哚布芬片

片剂

0.2g

化学药品

December 1, 2024

Company Information

Applicant Company

北京市顺义区中北工业区(北石槽镇)

Manufacturing Company

北京市顺义区中北工业区(北石槽镇)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吲哚布芬片 - NMPA 批准文号 | MedPath